FDA device listing

Lumipulse G B-Amyloid 1-42-N Plasma Calibrators,Lumipulse G B-Amyloid 1-42-N Plasma IC,Lumipulse G pTau217/B-Amyloid…

FDA device listing 1470287116 · Fujirebio Diagnostics, Inc.

Key facts

Proprietary names Lumipulse G B-Amyloid 1-42-N Plasma Calibrators,Lumipulse G B-Amyloid 1-42-N Plasma IC,Lumipulse G pTau217/B-Amyloid 1-42 Plasma Ratio,Lumipulse G pTau 217 Plasma Calibrators,Lumipulse G pTau 217 Plasma IC
Owner/operator Fujirebio Diagnostics, Inc.
Owner/operator number 10022860
Premarket submissions K242706
Product codes SET
Device names SET - Immunoassay Blood Test For Amyloid Pathology Assessment
Device class Class II
Classification regulations (21 CFR) 866.5840
Review panels Immunology
Registered establishments Fujirebio Diagnostics, Inc., Fujirebio Europe N.V., Fujirebio Inc.
Establishment registrations 2521625, 9615837, 3002895169
FEI numbers 2521625, 3002608770, 3002895169
Establishment operations Manufacturer
Registration valid through 2026

At a glance

  • 1–9 Registered establishments listing this device
  • 1–9 UDI devices (GUDID) under the same submission
  • 1–9 Device listings citing the same submission
  • Yes Premarket submission listed

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA device listings

Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.

Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database

Browse all FDA device listings